Using electronic tools to track symptoms in colorectal cancer patients
To Examine Whether a Complex Intervention Protocol Decreases Toxicity in Patients Following Radiotherapy or Surgery for Colorectal Cancer. Stage 1- Feasibility of Electronic Data Collection
This study tests if using electronic tools to track symptoms can help doctors better understand and support colorectal cancer patients before and after their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Royal Surrey County Hospital NHS Foundation Trust Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Guildford, Surrey) |
| Trial ID | NCT04697394 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the feasibility of using electronic Patient-Reported Outcome Measures (PROMs) to collect symptom data from colorectal cancer patients before and after treatment. Patients will answer health-related questions at the start and during their treatment, allowing for a more accurate understanding of their symptoms compared to traditional methods. The collected data will help doctors provide better information to future patients and identify those who may need additional support. By utilizing an electronic database, the study seeks to uncover patterns in patient-reported symptoms that could inform future treatment strategies.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with colorectal cancer who are scheduled for surgery or radiotherapy and can complete an online questionnaire.
Not a fit: Patients with metastatic disease or those unable to complete the electronic questionnaire may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate symptom management and improved quality of life for colorectal cancer patients.
How similar studies have performed: Other studies utilizing electronic PROMs have shown success in improving patient outcomes, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with colorectal cancer from the 5 participating centres (Guilford, Clatterbridge, Nottingham, Queens Hospital and Hull) * No distant metastases * Patients due to undergo surgery or radiotherapy as a definitive treatment * ≥ 18 years of age. No maximum age. * The ability to complete an internet based English written questionnaire either from their home or on a portable electronic device * Patients to have read the patient information sheet and have electronically signed the informed consent * Follow-up in clinic possible Exclusion Criteria: * Patient choice * \< 18 years of age * Evidence of metastatic disease * History of other cancer less than five years ago, excluding non-melanoma skin cancer * Evidence of metastatic disease-patients not undergoing surgery or radiotherapy as a definitive treatment * The inability to complete an internet based English written questionnaire at home or on a portable electronic device * Patient with history of poor compliance or current or past psychiatric conditions that would interfere with compliance to the study protocol or cause further psychological distress.
Where this trial is running
Guildford, Surrey
- Royal Surrey County NHS Foundation Trust — Guildford, Surrey, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Alexandra Stewart, DM, MRCP, FRCR — Consultant Clinical Oncologist, Royal Surrey County Hospital
- Study coordinator: Dr Alexandra Stewart, DM, MRCP, FRCR
- Email: rsch.citrustrial@nhs.net
- Phone: +441483 571122
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.